Skip to main content
logo
Nutra Pharma Corp. (NPHC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Nov 6, 2026

Nutra Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1110115
Market Cap Growth
9984.13%0%9949.17%-99.07%-94.81%106.12%
Enterprise Value
131098923
Last Close Price
0.000.000.000.000.000.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----0.09-
PS Ratio
2.771.841.810.011.73149.92
PB Ratio
--0.04-0.050.00-0.06-0.70

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
50.4427.0122.4913.6420.23238.66

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.58-0.67-0.67-0.68-0.69-0.40
Net Debt / Equity Ratio
-0.58-0.67-0.67-0.67-0.69-0.40
Net Debt / EBITDA Ratio
-7.58-7.80-11.38-10.67-4.54-4.19
Net Debt / FCF Ratio
-11.75-9.51-23.37-16.86-10.42-4.66
Asset Turnover
0.350.650.630.850.570.18
Inventory Turnover
6.8010.147.789.146.864.88
Quick Ratio
0.010.010.010.010.000.01
Current Ratio
0.020.030.030.020.030.03
Return on Assets (ROA)
-138.06%-154.38%-88.56%-79.46%-155.33%-229.76%
Return on Capital Employed (ROCE)
7.80%8.80%6.00%6.60%16.00%9.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-682.00%-288.38%-181.09%-19721.95%1076.35%-89.38%
FCF Yield
-146.60%-167.61%-59.71%-7785.36%-107.99%-12.17%
Buyback Yield / Dilution
-3.11%-1.37%-0.87%60.16%-164.03%-9.46%